Peptide with gold binding and EGFR receptor affinity and same attached to gold nanostructure

US9766252B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9766252-B2
Application numberUS-201314386269-A
CountryUS
Kind codeB2
Filing dateMar 13, 2013
Priority dateMar 22, 2012
Publication dateSep 19, 2017
Grant dateSep 19, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An embodiment of the invention is a peptide comprising four domains, wherein domain I consists of thioctyl or monocytl, domain II consists of 2 to 3 positively charged amino acids selected from the group consisting of lysine and arginine, domain III consists of a dimeric ethylene unit; and domain IV comprises the peptide with SEQ ID No. 1 or a sequence having at least 90% identity to SEQ ID No. I. The peptide is preferably attached to a gold nanostructure, preferably a gold nanorod to provide an EFGR kit. An EFGR detection kit of the invention employs a gold nanostructure attached to a peptide sequence, the peptide sequence includes a binding sequence with an affinity toward EGFR, a ligand bound to gold atoms of the nanorod, a positively charged amino acid that maintains activity of the binding sequence, and a unit that increases hydrophilicity of the peptide sequence.

First claim

Opening claim text (preview).

The invention claimed is: 1. A peptide comprising four domains, wherein domain I consists of thioctyl or monothiol, domain II consists of 2 to 3 positively charged amino acids selected from the group consisting of lysine and arginine, domain III consists of a dimeric ethylene unit; and domain IV comprises the peptide with SEQ ID No. 1. 2. The peptide of claim 1 , wherein domain I consists of thioctyl. 3. The peptide of claim 2 , wherein domain II consists of 2 molecules of lysine. 4. The peptide of claim 1 , attached to a gold nanostructure. 5. The peptide of claim 4 , wherein the gold nanostructure comprises a gold nanorod. 6. An epidermal growth factor receptor (EGFR) detection kit comprising a solution of peptides attached to the gold nanorod according to claim 5 . 7. An epidermal growth factor receptor (EGFR) detection kit comprising a solution of peptides attached to gold nanorods according to claim 4 . 8. An epidermal growth factor receptor (EGFR) detection kit comprising: a gold nanostructure attached to a peptide comprising four domains, wherein domain I consists of thioctyl or monothiol, domain II consists of 2 to 3 positively charged amino acids selected from the group consisting of lysine and arginine, domain III consists of a dimeric ethylene unit and domain IV comprises the peptide with SEQ ID No. 1. 9. The EGFR detection kit of claim 8 , wherein the positively charged amino acids consists of 2 or 3 molecules of lysine. 10. An epidermal growth factor receptor (EGFR) detection kit comprising a solution of peptides attached to the gold nanostructure according to claim 4 .

Assignees

Inventors

Classifications

  • Peptides being immobilised on, or in, an inorganic carrier · CPC title

  • Intracellular protein regulatory factors and their receptors, e.g. including ion channels · CPC title

  • Nanoparticles · CPC title

  • Epidermal growth factor [EGF] (urogastrone) · CPC title

  • having 12 to 20 amino acids (gastrins C07K14/595; somatostatins C07K14/655; melanotropins C07K14/68) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9766252B2 cover?
An embodiment of the invention is a peptide comprising four domains, wherein domain I consists of thioctyl or monocytl, domain II consists of 2 to 3 positively charged amino acids selected from the group consisting of lysine and arginine, domain III consists of a dimeric ethylene unit; and domain IV comprises the peptide with SEQ ID No. 1 or a sequence having at least 90% identity to SEQ ID No.…
Who is the assignee on this patent?
Univ Missouri
What technology area does this patent fall under?
Primary CPC classification G01N33/6872. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Sep 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).